Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004205 |
---|---|
Receipt number | R000004947 |
Scientific Title | Open labeled, single arm, multi centered, phase II trial to evaluate the efficacy and safety of combination therapy of rituximab and cladribine for previously untreated patients with advanced staged extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and nodal marginal zone B-cell lymphoma |
Date of disclosure of the study information | 2010/09/15 |
Last modified on | 2012/06/28 11:04:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/14 16:21:32 | ||
2 | Update | 2010/11/04 09:41:38 | Recruitment status |
|
3 | Update | 2011/01/25 15:31:38 | UMIN ID1 |
|
4 | Update | 2012/06/28 11:04:30 | Key inclusion criteria Key inclusion criteria |